Hiroshi Kajinuma

1.3k total citations
42 papers, 1.0k citations indexed

About

Hiroshi Kajinuma is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Hiroshi Kajinuma has authored 42 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Hiroshi Kajinuma's work include Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (13 papers) and Pancreatic function and diabetes (12 papers). Hiroshi Kajinuma is often cited by papers focused on Diabetes Treatment and Management (13 papers), Metabolism, Diabetes, and Cancer (13 papers) and Pancreatic function and diabetes (12 papers). Hiroshi Kajinuma collaborates with scholars based in Japan, United States and Canada. Hiroshi Kajinuma's co-authors include Kinori Kosáka, AKIO KANETO, Nobusada Kuzuya, Ryoko Hagura, Takashi Kadowaki, Takeshi Kuzuya, Y Akanuma, Fumimaro Takaku, Yasuo Akanuma and Toshio Kaneko and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Hiroshi Kajinuma

40 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Kajinuma Japan 17 503 363 315 203 163 42 1.0k
L. Kennedy United States 19 741 1.5× 351 1.0× 213 0.7× 178 0.9× 134 0.8× 48 1.3k
T. Kunt Germany 21 698 1.4× 490 1.3× 315 1.0× 346 1.7× 359 2.2× 39 1.5k
N. Sakamoto Japan 20 229 0.5× 120 0.3× 252 0.8× 273 1.3× 38 0.2× 60 1.2k
P. Micossi Italy 18 557 1.1× 273 0.8× 250 0.8× 85 0.4× 123 0.8× 52 967
W. M. Bennet United Kingdom 20 318 0.6× 284 0.8× 420 1.3× 515 2.5× 109 0.7× 41 1.4k
Per Manhem Sweden 18 579 1.2× 245 0.7× 166 0.5× 253 1.2× 104 0.6× 45 1.2k
Richard D. Carr Denmark 15 482 1.0× 382 1.1× 306 1.0× 247 1.2× 152 0.9× 24 1.2k
Denis Ikkos Sweden 13 334 0.7× 153 0.4× 610 1.9× 247 1.2× 95 0.6× 27 1.2k
Udaya M. Kabadi United States 19 789 1.6× 174 0.5× 214 0.7× 219 1.1× 149 0.9× 112 1.2k
Buris R. Boshell United States 19 300 0.6× 132 0.4× 282 0.9× 292 1.4× 59 0.4× 44 850

Countries citing papers authored by Hiroshi Kajinuma

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Kajinuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kajinuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kajinuma more than expected).

Fields of papers citing papers by Hiroshi Kajinuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Kajinuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kajinuma. The network helps show where Hiroshi Kajinuma may publish in the future.

Co-authorship network of co-authors of Hiroshi Kajinuma

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kajinuma. A scholar is included among the top collaborators of Hiroshi Kajinuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kajinuma. Hiroshi Kajinuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kajinuma, Hiroshi, et al.. (1997). Changes in Plasma Glucose, Insulin, Glucagon, Catecholamine, and Glycogen Contents in Tissues during Development of Alloxan Diabetes Mellitus in Rats. Biochemical and Molecular Medicine. 62(1). 70–75. 11 indexed citations
2.
Kuzuya, Takeshi, Yasuhiko Iwamoto, Kinori Kosaka, et al.. (1991). A pilot clinical trial of a new oral hypoglycemic agent, CS-045, in patients with non-insulin dependent diabetes mellitus. Diabetes Research and Clinical Practice. 11(3). 147–153. 44 indexed citations
3.
Irie, Minoru, et al.. (1990). Glucagon Inhibits Insulin Activation of Glucose Transport in Rat Adipocytes Mainly through a Postbinding Process. Endocrinology. 127(3). 1072–1077. 7 indexed citations
4.
Watanabe, Kyoko, et al.. (1990). Adrenalectomy-Induced Alterations in Glucagon Binding and Lipolysis in Isolated Rat Adipocytes. Hormone and Metabolic Research. 22(4). 215–220. 5 indexed citations
5.
Watanabe, Kyoko, Ryoko Hagura, Yasuo Akanuma, et al.. (1990). Characteristics of cranial nerve palsies in diabetic patients. Diabetes Research and Clinical Practice. 10(1). 19–27. 85 indexed citations
6.
Sato, Nobuyuki, Minoru Irie, Hiroshi Kajinuma, & Kazuo Suzuki. (1989). Decreased glucagon binding and glucagon-stimulated lipolysis in adipocytes from streptozotocin-diabetic rats. European Journal of Endocrinology. 121(5). 705–713. 3 indexed citations
7.
Suzuki, Kazuo, Hajime Miyata, Takashi Suzuki, & Hiroshi Kajinuma. (1989). Evaluation and Clinical Applications of Measurement of Urinary Growth Hormone in Diabetic Subjects. Diabetes. 38(12). 1567–1572. 7 indexed citations
8.
Suzuki, Kazuo, et al.. (1989). High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity. Diabetes Research and Clinical Practice. 6(1). 45–52. 28 indexed citations
9.
Suzuki, Masami, Kiyohiko Negishi, Jun Ishii, et al.. (1987). Initial Phase II Clinical Studies on Midaglizole (DG-5128): A New Hypoglycemic Agent. Diabetes. 36(2). 221–226. 27 indexed citations
10.
Tanabashi, Shinobu, et al.. (1984). [Metabolism of the blood insulin and C-peptide in acute hepatitis].. PubMed. 73(1). 7–13. 1 indexed citations
11.
Kadowaki, Takashi, Ryoko Hagura, Hiroshi Kajinuma, Nobusada Kuzuya, & Sho Yoshida. (1983). Chlorpropamide-induced Hyponatremia: Incidence and Risk Factors. Diabetes Care. 6(5). 468–471. 39 indexed citations
12.
Kajinuma, Hiroshi, et al.. (1982). Changes in Serum Levels After Oral Administration. 25(8). 877–883. 1 indexed citations
13.
KANETO, AKIO, et al.. (1978). Effect of bombesin infused intrapancreatically on glucagon and insulin secretion. Metabolism. 27(5). 549–553. 41 indexed citations
14.
KANETO, AKIO, Hiroshi Kajinuma, Toshio Kaneko, & Kinori Kosáka. (1978). Effect of phentolamine on the somatostatin-induced inhibition of glucagon and insulin secretion. Metabolism. 27(8). 901–910. 5 indexed citations
15.
KANETO, AKIO, Toshio Kaneko, Hiroshi Kajinuma, & Kinori Kosáka. (1977). Effect of vasoactive intestinal polypeptide infused intrapancreatically on glucagon and insulin secretion. Metabolism. 26(7). 781–786. 23 indexed citations
16.
Kuzuya, Takeshi, Hiroshi Kajinuma, & Takehiko Idé. (1974). Effect of Intrapancreatic Injection of Potassium and Calcium on Insulin and Glucagon Secretion in Dogs. Diabetes. 23(1). 55–60. 21 indexed citations
17.
Kajinuma, Hiroshi, et al.. (1973). [Application of blood insulin determination in diagnosis of diabetes mellitus and its theoretical basis].. PubMed. 31(7). 2218–26.
18.
Kajinuma, Hiroshi, Takehiko Idé, Takeshi Kuzuya, & Kinori Kosáka. (1969). Insulin-like Activity by Fat Pad Assay and Immunoreactive Insulin: II. Their Occurrence in Fractions by Gel Filtration of Serum. Diabetes. 18(2). 75–83. 10 indexed citations
19.
Idé, Takehiko, Takeshi Kuzuya, Hiroshi Kajinuma, Yasunori Kanazawa, & Kinori Kosáka. (1969). Insulin-like Activity by Fat Pad Assay and Immunoreactive Insulin: I. Their Correlation in Native Serum, Acid-ethanol Extract and Salt-ethanol Extract. Diabetes. 18(2). 65–74. 4 indexed citations
20.
Kajinuma, Hiroshi, AKIO KANETO, Takeshi Kuzuya, & Kiku Nakao. (1968). Effects of Methacholine on Insulin Secretion in Man. The Journal of Clinical Endocrinology & Metabolism. 28(9). 1384–1388. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Kennedy Breakdown of academic impact, for papers by T. Kunt Breakdown of academic impact, for papers by N. Sakamoto Breakdown of academic impact, for papers by P. Micossi Breakdown of academic impact, for papers by W. M. Bennet Breakdown of academic impact, for papers by Per Manhem Breakdown of academic impact, for papers by Richard D. Carr Breakdown of academic impact, for papers by Denis Ikkos Breakdown of academic impact, for papers by Udaya M. Kabadi Breakdown of academic impact, for papers by Buris R. Boshell
Rankless by CCL
2026